🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#CochranePodcast - In Jan '22, we published a new review of a group of #COVID19 treatments called interleukin-1 blocking agents. Lead author, Mauricia Davidson from Cochrane France tells us about the findings. buff.ly/3rhWe8K 🎧 Also available on Spotify Apple Podcasts

Thoracotomy on stage!!! Trauma surgeon extraordinaire Kenji Inaba walks everyone through the procedure, at #emrap_one EM:RAP

LAST CHANCE! Today is the final day to register for the 3-day Network Meta-Analysis course in Biarritz 🖱️cer-methods.com/2021/12/09/nma… #sun #sea #NMA

"Why preprints are good for patients” by Peter Horby @peterhorby.bsky.social, author of the RECOVERY trial nature.com/articles/s4159…

Once again, we have released our latest Summary of Main Results! bit.ly/3B4IBze

We offer a 3-year fully-funded PhD position on methods for Evidence Synthesis!! Come and join us in Paris and enjoy working within a multidisciplinary and highly motivated team! More information and contact details at cer-methods.com/join-us/ Closing date: 5 September

📢The fifth edition of the #COVIDNMA Summary of Main Results is out! Click the link to see the results regarding treatments of hospitalized #COVID19 patients up to August 3rd, 2022 bit.ly/3Pe3qMl

Happy to have presented our work on comparing results between #Covid preprint-publication RCTs #PRC9

Was left wondering if there was an eject button nearby😅 Ben Willem Mol let's discuss #PRC9

#WeekInReview Congrats to Mauricia Davidson on her great presentation at #PRC9 comparing numerical results between #COVID19 treatment trials first available as preprints & subsequently published in peer-reviewed journals #metaresearch 🌐 covid-nma.com

Fascinating keynote from @IsabelleBoutron at #ICTMC2022 , ending with the message that we can always do more to ensure better trials

Our review including 41 randomized controlled trials on #COVID19 #vaccines has been published! What are the benefits and risks of vaccines for preventing COVID-19? 👉cochrane.org/CD015477/EMERG…

No evidence of important difference in summary treatment effects between COVID-19 preprints and peer-reviewed publications: a meta-epidemiological study - Journal of Clinical Epidemiology jclinepi.com/article/S0895-…

Mauricia Davidson no important differences between preprint and peer-reviewed publication effect estimates in COVID-19 trials #cochranelondon

Ioannidis JPA, Berkwits M, Flanagin A, Bloom T. Peer Review and Scientific Publication at a Crossroads: Call for Research for the 10th International Congress on Peer Review and Scientific Publication. JAMA. 2023 Sep 22. doi: 10.1001/jama.2023.17607. jamanetwork.com/journals/jama/…

Published! Our paper is now available #openaccess in Journal of Clinical Epidemiology 👉jclinepi.com/article/S0895-… Theodoros Evrenoglou Carolina Anna Chaimani @IsabelleBoutron

Our paper has just been #published ! "Effect estimates were generally consistent between #COVID19 #preprints & subsequent journal articles. Main results & interpretations did not change" Read it here 👉 shorturl.at/qDEK1 @IsabelleBoutron Anna Chaimani Theodoros Evrenoglou Carolina

“Preprints are often bad quality and lead to the propagation of big lies …” … seems not to be true for the COVID literature when comparing preprints and papers that passed official journal peer review. This is no surprise of course.

Check our new article "Exploring the Effectiveness of Self-Management Interventions in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis" , published a few days ago! pubmed.ncbi.nlm.nih.gov/38200933/ #evidencebasedmedicine #SelfManagementInterventions #Type2Diabetes

We want to thank Mauricia Davidson for her presentation on comparison of effect estimates. Watch the recap here: youtu.be/jjd1idzVPeg?si… Join us tomorrow at 9 AM Pacific Time for another METRICS International Forum session with Antica Culina @anticac.bsky.soc Link below stanford.zoom.us/j/92985438446?…